Yuan Ma1, Feng J He1, Qi Sun1, Changzheng Yuan1, Lyanne M Kieneker1, Gary C Curhan1, Graham A MacGregor1, Stephan J L Bakker1, Norm R C Campbell1, Molin Wang1, Eric B Rimm1, JoAnn E Manson1, Walter C Willett1, Albert Hofman1, Ron T Gansevoort1, Nancy R Cook1, Frank B Hu1. 1. From the Departments of Epidemiology (Y.M., Q.S., G.C.C., M.W., E.B.R., J.E.M., W.C.W., A.H., N.R.C., F.B.H.) and Nutrition (Q.S., C.Y., E.B.R., W.C.W., F.B.H.), Harvard T.H. Chan School of Public Health, and the Channing Division of Network Medicine, the Department of Medicine (Q.S., G.C.C., E.B.R., J.E.M., W.C.W., F.B.H.), Renal Division, the Department of Medicine (G.C.C.), and the Division of Preventive Medicine (J.E.M., N.R.C.), Brigham and Women's Hospital and Harvard Medical School - all in Boston; the Wolfson Institute of Population Health, St. Bartholomew's Hospital and the London School of Medicine and Dentistry, Queen Mary University of London, London (F.J.H., G.A.M.); the Department of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (L.M.K., S.J.L.B., R.T.G.); and the Departments of Medicine, Community Health Sciences, and Physiology and Pharmacology, O'Brien Institute of Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, AB, Canada (N.R.C.C.).
Abstract
BACKGROUND: The relation between sodium intake and cardiovascular disease remains controversial, owing in part to inaccurate assessment of sodium intake. Assessing 24-hour urinary excretion over a period of multiple days is considered to be an accurate method. METHODS: We included individual-participant data from six prospective cohorts of generally healthy adults; sodium and potassium excretion was assessed with the use of at least two 24-hour urine samples per participant. The primary outcome was a cardiovascular event (coronary revascularization or fatal or nonfatal myocardial infarction or stroke). We analyzed each cohort using consistent methods and combined the results using a random-effects meta-analysis. RESULTS: Among 10,709 participants, who had a mean (±SD) age of 51.5±12.6 years and of whom 54.2% were women, 571 cardiovascular events were ascertained during a median study follow-up of 8.8 years (incidence rate, 5.9 per 1000 person-years). The median 24-hour urinary sodium excretion was 3270 mg (10th to 90th percentile, 2099 to 4899). Higher sodium excretion, lower potassium excretion, and a higher sodium-to-potassium ratio were all associated with a higher cardiovascular risk in analyses that were controlled for confounding factors (P≤0.005 for all comparisons). In analyses that compared quartile 4 of the urinary biomarker (highest) with quartile 1 (lowest), the hazard ratios were 1.60 (95% confidence interval [CI], 1.19 to 2.14) for sodium excretion, 0.69 (95% CI, 0.51 to 0.91) for potassium excretion, and 1.62 (95% CI, 1.25 to 2.10) for the sodium-to-potassium ratio. Each daily increment of 1000 mg in sodium excretion was associated with an 18% increase in cardiovascular risk (hazard ratio, 1.18; 95% CI, 1.08 to 1.29), and each daily increment of 1000 mg in potassium excretion was associated with an 18% decrease in risk (hazard ratio, 0.82; 95% CI, 0.72 to 0.94). CONCLUSIONS: Higher sodium and lower potassium intakes, as measured in multiple 24-hour urine samples, were associated in a dose-response manner with a higher cardiovascular risk. These findings may support reducing sodium intake and increasing potassium intake from current levels. (Funded by the American Heart Association and the National Institutes of Health.).
BACKGROUND: The relation between sodium intake and cardiovascular disease remains controversial, owing in part to inaccurate assessment of sodium intake. Assessing 24-hour urinary excretion over a period of multiple days is considered to be an accurate method. METHODS: We included individual-participant data from six prospective cohorts of generally healthy adults; sodium and potassium excretion was assessed with the use of at least two 24-hour urine samples per participant. The primary outcome was a cardiovascular event (coronary revascularization or fatal or nonfatal myocardial infarction or stroke). We analyzed each cohort using consistent methods and combined the results using a random-effects meta-analysis. RESULTS: Among 10,709 participants, who had a mean (±SD) age of 51.5±12.6 years and of whom 54.2% were women, 571 cardiovascular events were ascertained during a median study follow-up of 8.8 years (incidence rate, 5.9 per 1000 person-years). The median 24-hour urinary sodium excretion was 3270 mg (10th to 90th percentile, 2099 to 4899). Higher sodium excretion, lower potassium excretion, and a higher sodium-to-potassium ratio were all associated with a higher cardiovascular risk in analyses that were controlled for confounding factors (P≤0.005 for all comparisons). In analyses that compared quartile 4 of the urinary biomarker (highest) with quartile 1 (lowest), the hazard ratios were 1.60 (95% confidence interval [CI], 1.19 to 2.14) for sodium excretion, 0.69 (95% CI, 0.51 to 0.91) for potassium excretion, and 1.62 (95% CI, 1.25 to 2.10) for the sodium-to-potassium ratio. Each daily increment of 1000 mg in sodium excretion was associated with an 18% increase in cardiovascular risk (hazard ratio, 1.18; 95% CI, 1.08 to 1.29), and each daily increment of 1000 mg in potassium excretion was associated with an 18% decrease in risk (hazard ratio, 0.82; 95% CI, 0.72 to 0.94). CONCLUSIONS: Higher sodium and lower potassium intakes, as measured in multiple 24-hour urine samples, were associated in a dose-response manner with a higher cardiovascular risk. These findings may support reducing sodium intake and increasing potassium intake from current levels. (Funded by the American Heart Association and the National Institutes of Health.).
Authors: Feng J He; Norm R C Campbell; Yuan Ma; Graham A MacGregor; Mary E Cogswell; Nancy R Cook Journal: Int J Epidemiol Date: 2018-12-01 Impact factor: 7.196
Authors: Laura K Cobb; Cheryl A M Anderson; Paul Elliott; Frank B Hu; Kiang Liu; James D Neaton; Paul K Whelton; Mark Woodward; Lawrence J Appel Journal: Circulation Date: 2014-02-10 Impact factor: 29.690
Authors: Kirsten Bibbins-Domingo; Glenn M Chertow; Pamela G Coxson; Andrew Moran; James M Lightwood; Mark J Pletcher; Lee Goldman Journal: N Engl J Med Date: 2010-01-20 Impact factor: 91.245
Authors: Dariush Mozaffarian; Saman Fahimi; Gitanjali M Singh; Renata Micha; Shahab Khatibzadeh; Rebecca E Engell; Stephen Lim; Goodarz Danaei; Majid Ezzati; John Powles Journal: N Engl J Med Date: 2014-08-14 Impact factor: 91.245
Authors: Martin Gritter; Rosa D Wouda; Stanley M H Yeung; Michiel L A Wieërs; Frank Geurts; Maria A J de Ridder; Christian R B Ramakers; Liffert Vogt; Martin H de Borst; Joris I Rotmans; Ewout J Hoorn Journal: J Am Soc Nephrol Date: 2022-05-24 Impact factor: 14.978
Authors: Norm R C Campbell; Paul K Whelton; Marcelo Orias; Richard D Wainford; Francesco P Cappuccio; Nicole Ide; Bruce Neal; Jennifer Cohn; Laura K Cobb; Jacqui Webster; Kathy Trieu; Feng J He; Rachael M McLean; Adriana Blanco-Metzler; Mark Woodward; Nadia Khan; Yoshihiro Kokubo; Leo Nederveen; JoAnne Arcand; Graham A MacGregor; Mayowa O Owolabi; Liu Lisheng; Gianfranco Parati; Daniel T Lackland; Fadi J Charchar; Bryan Williams; Maciej Tomaszewski; Cesar A Romero; Beatriz Champagne; Mary R L'Abbe; Michael A Weber; Markus P Schlaich; Agnes Fogo; Valery L Feigin; Rufus Akinyemi; Felipe Inserra; Bindu Menon; Marcia Simas; Mario Fritsch Neves; Krassimira Hristova; Carolyn Pullen; Sanjay Pandeya; Junbo Ge; Jorge E Jalil; Ji-Guang Wang; Jiri Wideimsky; Reinhold Kreutz; Ulrich Wenzel; Michael Stowasser; Manuel Arango; Athanasios Protogerou; Eugenia Gkaliagkousi; Flávio Danni Fuchs; Mansi Patil; Andy Wai-Kwong Chan; János Nemcsik; Ross T Tsuyuki; Sanjeevi Nathamuni Narasingan; Nizal Sarrafzadegan; María Eugenia Ramos; Natalie Yeo; Hiromi Rakugi; Agustin J Ramirez; Guillermo Álvarez; Adel Berbari; Cho-Il Kim; Sang-Hyun Ihm; Yook-Chin Chia; Tsolmon Unurjargal; Hye Kyung Park; Kolawole Wahab; Helen McGuire; Naranjargal J Dashdorj; Mohammed Ishaq; Deborah Ignacia D Ona; Leilani B Mercado-Asis; Aleksander Prejbisz; Marianne Leenaerts; Carla Simão; Fernando Pinto; Bader Ali Almustafa; Jonas Spaak; Stefan Farsky; Dragan Lovic; Xin-Hua Zhang Journal: J Hum Hypertens Date: 2022-05-17 Impact factor: 2.877
Authors: Dong D Wang; Yanping Li; Xuan-Mai T Nguyen; Rebecca J Song; Yuk-Lam Ho; Frank B Hu; Walter C Willett; Peter W F Wilson; Kelly Cho; J Michael Gaziano; Luc Djoussé Journal: Nutrients Date: 2022-03-07 Impact factor: 6.706
Authors: Francesco P Cappuccio; Norm R C Campbell; Feng J He; Michael F Jacobson; Graham A MacGregor; Elliott Antman; Lawrence J Appel; JoAnne Arcand; Adriana Blanco-Metzler; Nancy R Cook; Juliet R Guichon; Mary R L'Abbè; Daniel T Lackland; Tim Lang; Rachael M McLean; Marius Miglinas; Ian Mitchell; Frank M Sacks; Peter S Sever; Meir Stampfer; Pasquale Strazzullo; Wayne Sunman; Jacqui Webster; Paul K Whelton; Walter Willett Journal: Curr Nutr Rep Date: 2022-02-14